23andMe is in trouble. What happens to all the DNA data?
Sep 25, 2024 · Once a hot $6 billion biotech company, 23andMe is now on the verge of collapse. What could happen to the DNA data of its 14 million customers? AILSA CHANG, HOST: The genetic testing company...
23andMe is on the verge of bankruptcy. It may be too late to …
Oct 16, 2024 · Popular genetic testing company 23andMe is facing bankruptcy and may sell the genetic data of its 15 million customers. Users have the option to delete their data, but the company can retain it for three years. Data that's already been sold to researchers may not be able to be deleted. What's next?
What happened to 23andMe? | CNN Business
Sep 20, 2024 · 23andMe has tried to convert one-time buyers into subscribers with the promise of continued feedback and personalized wellness plans. But, as the Wall Street Journal wrote in January, the company...
What happens to all of 23andMe's genetic DNA data? : NPR
Oct 3, 2024 · According to 23andMe’s transparency report, authorities have sought genetic data on 15 individuals since 2015, but the company has resisted the requests and never produced data for...
Inside the fall of 23andMe
Oct 23, 2024 · Founded in 2006, 23andMe set out to revolutionize the once very exclusive genetic testing business with a direct-to-consumer model. Thanks to capital from high-profile backers …
As 23andMe Struggles, Concerns Surface About Its Genetic Data
Oct 5, 2024 · The genetic testing company 23andMe, once valued at $6 billion, is facing an uncertain future after a drop in share prices, a recent board resignation and a data breach last year that affected...
23andMe is in trouble. What happens to all the DNA data?
Sep 25, 2024 · The genetic testing company 23andMe went from biotech superstar to the brink of collapse. Its most valuable asset might be its DNA data. NPR's Bobby Allyn reports on what might happen to the genetic information of millions of people.
23andMe directors resign as the CEO of the ... - Associated Press News
Sep 19, 2024 · NEW YORK (AP) — All of 23andMe’s independent directors resigned from its board this week, a rare move that marks the latest challenge for the genetic-testing company. The resignations follow drawn-out negotiations with 23andMe CEO and co-founder Anne Wojcicki, who wants to take the company private.
Tech expert warns your 23andMe genetic data could be at risk
2 days ago · 23andMe has already let 40% of its employees go after its entire board resigned in September. New York does have narrow consumer privacy laws in effect, but Vishwanath says a new owner could ...
23andMe Is Under Fire. Its Founder Remains ‘Optimistic’
Feb 12, 2024 · Valued at $6 billion in 2021 when it went public, 23andMe now risks being delisted from the Nasdaq as its stock continues to trade below $1 a share. And like many Silicon Valley startups, it’s...